Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups

Khayat, Mohamed N M T Al; Eijsink, Jasper J.H.; Postma, Maarten J.; Garde, E.M.W. van de; Hulst, Marinus van

doi:10.1007/s10198-021-01422-w

Cited by 9 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In total, 16 (48%) studies present ACERs rather than ICERs [ 25 , 30 , 39 – 52 ]. An additional 6 (18%) studies estimate ICERs of annual screening without assessment against biennial comparators [ 28 , 32 – 36 ]. A further 2 (6%) studies are classified as reporting ICERs as they have assessed one-time screening per lifetime [ 30 , 31 ].…”

Section: Resultsmentioning

confidence: 99%

“…As the latter is more comprehensively reported we excluded the former. Three additional studies were found from citation tracking [27][28][29]. Ultimately, 33 articles were accepted for critical appraisal.…”

Section: Overviewmentioning

confidence: 99%

“…The studies in Category 1B all estimate the ACERs of the given strategies relative to no screening. The four studies in Category 1C estimate ICERs between alternative screening ages, but do not vary the screening frequency to include intervals such as 2 years or longer [28,[34][35][36]. Within Category 2, Goffin et al estimate an ICER between annual versus biennial screening [37].…”

Section: Comparisons and Cost-effectiveness Ratiosmentioning

confidence: 99%

“…In total, 16 (48%) studies present ACERs rather than ICERs [25,30,[39][40][41][42][43][44][45][46][47][48][49][50][51][52]]. An additional 6 (18%) studies estimate ICERs of annual screening without assessment against biennial comparators [28,[32][33][34][35][36]. A further 2 (6%) studies Fig.…”

Section: Comparisons and Cost-effectiveness Ratiosmentioning

confidence: 99%

See 3 more Smart Citations

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

Fabbro

Hahn

Novaes

et al. 2022

PharmacoEconomics Open

View full text Add to dashboard Cite

Objectives Our first study objective was to assess the range of lung cancer screening intervals compared within cost-effectiveness analyses (CEAs) of low-dose computed tomography (LDCT) and to examine the implications for the strategies identified as optimally cost effective; the second objective was to examine if and how risk subgroup-specific policies were considered. Methods PubMed, Embase and Web of Science were searched for model-based CEAs of LDCT lung screening. The retrieved studies were assessed to examine if the analyses considered sufficient strategy variation to permit incremental estimation of cost effectiveness. Regarding risk selection, we examined if analyses considered alternative risk strata in separate analyses or as alternative risk-based eligibility criteria for screening. ResultsThe search identified 33 eligible CEAs, 23 of which only considered one screening frequency. Of the 10 analyses considering multiple screening intervals, only 4 included intervals longer than 2 years. Within the 10 studies considering multiple intervals, the optimal policy choice would differ in 5 if biennial intervals or longer had not been considered. Nineteen studies conducted risk subgroup analyses, 12 of which assumed that subgroup-specific policies were possible and 7 of which assumed that a common screening policy applies to all those screened. Conclusions The comparison of multiple strategies is recognised as good practice in CEA when seeking optimal policies. Studies that do include multiple intervals indicate that screening intervals longer than 1 year can be relevant. The omission of intervals of 2 years or longer from CEAs of LDCT screening could lead to the adoption of sub-optimal policies. There also is scope for greater consideration of risk-stratified policies which tailor screening intensity to estimated disease risk. Policy makers should take care when interpreting current evidence before implementing lung screening.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Overviewmentioning

confidence: 99%

Section: Comparisons and Cost-effectiveness Ratiosmentioning

confidence: 99%

Section: Comparisons and Cost-effectiveness Ratiosmentioning

confidence: 99%

See 2 more Smart Citations

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

Fabbro

Hahn

Novaes

et al. 2022

PharmacoEconomics Open

View full text Add to dashboard Cite

show abstract

“…The implementation of population-based lung cancer screening of high-risk individuals could decrease the percentage of inoperable patients who are diagnosed with stage III (21%) and IV (49%) lung cancer. A Dutch-initiated randomized lung cancer screening trial, known as the NELSON trial, has recently proven to result in a decrease in lung cancer mortality by 26% and to be cost-effective in the Netherlands (67)(68)(69). Although lung cancer screening programs are currently implemented in several European centers (70), screening for lung cancer with low-dose computed tomography is presently not yet implemented in the Netherlands because of legal restrictions (67).…”

Section: Lung Cancer Screening Of High-risk Individualsmentioning

confidence: 99%

Thoracic surgery in the Netherlands

Laven¹,

Daemen²,

Jansen³

et al. 2022

J Thorac Dis

View full text Add to dashboard Cite

The purpose of this article, part of the Thoracic Surgery Worldwide series, is to provide a descriptive review of how thoracic surgery is organized in the Netherlands. General information is provided on the Dutch healthcare system, as well as on how Dutch thoracic surgeons are organized and trained.Additionally, this study provides information on our national quality surveillance system, an overview of the most common thoracic surgeries performed in our country, and details of academic research conducted by Dutch medical specialists. Furthermore, we discuss current challenges and future perspectives. In the Netherlands general thoracic surgical procedures are performed by approximately 110 general thoracic surgeons and 25 of the 135 cardiothoracic surgeons. Dutch thoracic surgeons provide minimally invasive lung surgery, chest wall surgery, thymic and mediastinal surgery, and surgical diagnosis and treatment of pleural disorders. Some recently published data on hospital mortality and postoperative adverse events of thoracic surgeries are reported. Furthermore, the structure of the thoracic surgical education and training program is discussed, highlighting the particular structure of two educational programs for thoracic surgery via a general thoracic and cardiothoracic surgery program. To assure high-quality surgical care, the Netherlands has a well-structured national quality surveillance system, involving frequent site visits and mandatory participation in the national lung cancer surgery registry for all hospitals. In terms of academic research, the Netherlands ranked 14th worldwide on number of clinical trials conducted across all medical disciplines in 2021. Furthermore, several thoracic-related (inter-)national multicenter randomized trials which are currently performed and initiated by Dutch hospital research groups are mentioned. Finally, future challenges and advances of Dutch thoracic surgery are addressed, including the implementation of lung cancer screening, imbalanced labor market, and centralization of care.

show abstract

Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations

et al. 2023

View full text Add to dashboard Cite

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups

Cited by 9 publications

References 13 publications

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

Thoracic surgery in the Netherlands

Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations

Contact Info

Product

Resources

About